Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson’s disease
Authors:
- 5 May 2023
- journal article
- research article
- Published by Elsevier in Progress in Neurobiology
- Vol. 226, 102462
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson modelProceedings of the National Academy of Sciences, 2013
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in NeuronsCell, 2013
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron DeathNeuron, 2011
- Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes MellitusPhysiological Reviews, 2011
- Diabetes and Risk of Parkinson’s DiseaseDiabetes Care, 2011
- Genome-wide association study reveals genetic risk underlying Parkinson's diseaseNature Genetics, 2009
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Permeability of the blood-brain barrier to amylinLife Sciences, 1995